Beta
Etoposide
medication Under reviewA chemotherapy medication and topoisomerase II inhibitor used to treat various types of cancer, including testicular and lung cancer.
Research summary
The human literature on etoposide is almost entirely in cancer patients rather than healthy volunteers, so there is no meaningful evidence base supporting supplement-style benefits in healthy humans. Available studies focus on pharmacology, treatment response, and toxicity in oncology settings, and the consensus is that etoposide is an effective chemotherapeutic agent with substantial dose-limiting toxicity. Across human studies and reviews, the most consistently documented adverse effect is myelosuppression, particularly leukopenia and thrombocytopenia. Higher cumulative exposure has also been associated with therapy-related acute myeloid leukemia, and the drug is recognized as carcinogenic in certain treatment contexts. No healthy-human studies support any general wellness benefit.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!